Author

Erika Plicanti

University of PisaORCID 0000-0002-5488-605XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. De CarliiD· 1 shared Alessandro MengozziiD· 1 shared Carolina FilipponiiD· 1 shared Elena IaconoiD· 1 shared Francesco FornaiiD· 1 shared Giulia FreeriD· 1 shared Giulia SciandroneiD· 1 shared Helena ObernolteiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. De CarliORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

N-acylethanolamine acid amidase inhibition reduces SARS-CoV-2 infection in Human Precision cut-lung slices and downregulates NF-kappaB signalling.

Veronica La Rocca, Carolina Filipponi, Viktoria Diesendorf, A. De Carli, Giulia Sciandrone, Silvia Nottoli, Erika Plicanti, Rossella Fonnesu, Elena Iacono, Alessandro Mengozzi, Stefano Masi, Paola Lenzi, Francesco Fornai, Katherina Sewald, Helena Obernolte, , Michele Lai

This study shows that inhibiting NAAA reduces SARS-CoV-2 replication in human lung tissue and suppresses NF-kappaB signaling.

Journal of Medical Virology · Jan 24, 2026Peer-reviewedMicrobiology